These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14383023)

  • 1. [Organization of anti-malaria protection in Siberia timberlands].
    PROKOPENKO LI
    Med Parazitol (Mosk); 1955; 24(1):34-40. PubMed ID: 14383023
    [No Abstract]   [Full Text] [Related]  

  • 2. [The malaria mosquitoes (Diptera, Culicidae, Anopheles) of the Amudarya river valley].
    Gordeev MI; Goriacheva II; Shaĭkevich EV; Zvantsev AB; Ezhov MN
    Med Parazitol (Mosk); 2006; (1):25-30. PubMed ID: 16562746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria vector control and personal protection.
    WHO Study Group
    World Health Organ Tech Rep Ser; 2006; 936():1-62, back cover. PubMed ID: 16623084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The problem of correct organization of malaria control in the Tartar ASSR].
    SARIKIAN SIa; CHECHEL'NIIKAIA SM; BAIGULOVA SA; LATYPOVA GKh; MILITSINA AN
    Med Parazitol (Mosk); 1958; 27(3):304-7. PubMed ID: 13565166
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of malaria among French adult travellers.
    Malvy D; Pistone T; Rezvani A; Lançon F; Vatan R; Receveur MC; Durand I; Hercberg S; El Hasnaoui A
    Travel Med Infect Dis; 2006 Sep; 4(5):259-69. PubMed ID: 16905456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Geographic malariological investigation of Azerbaidzhan as a basis for rational anti-malaria measures during a rapid decrease of malaria].
    BAGRAMIAN MG; TROFIMOV GK; NADZHAFOV AIu; KASIMOV AA; DZHAFAROV AA; KAVELIEV TKh
    Med Parazitol (Mosk); 1958; 27(3):278-83. PubMed ID: 13565161
    [No Abstract]   [Full Text] [Related]  

  • 8. [On organization of epidemiological inspection and verification of the liquidation of malaria at the Boradiginsk medical unit in the Masallinsk region of Azervaidzhan SSR].
    KUZNETSOV RL
    Med Parazitol (Mosk); 1962; 31():181-6. PubMed ID: 14037131
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO global report on malaria indicates progress on prevention.
    Skeet J
    Nurs Times; 2005 May 17-23; 101(20):42. PubMed ID: 15918462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malaria at the time of "Roll Back Malaria"].
    Le Bras M; Malvy D
    Med Trop (Mars); 2004; 64(6):576-8. PubMed ID: 15816134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village.
    Perraut R; Marrama L; Diouf B; Sokhna C; Tall A; Nabeth P; Trape JF; Longacre S; Mercereau-Puijalon O
    J Infect Dis; 2005 Jan; 191(2):264-71. PubMed ID: 15609237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current antimalarial drugs recommended by the World Health Organization for the treatment and prevention of malaria].
    Baranova AM
    Med Parazitol (Mosk); 2007; (3):56-9. PubMed ID: 17912843
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the fight against malaria].
    Nau JY
    Rev Med Suisse; 2008 Oct; 4(173):2121. PubMed ID: 18959082
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of malaria blood-stage vaccines: learning from mosquitoes.
    Butcher GA
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):530-1. PubMed ID: 17399756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological challenge to developing a vaccine to the blood stages of malaria parasites.
    Good MF; Stanisic D; Xu H; Elliott S; Wykes M
    Immunol Rev; 2004 Oct; 201():254-67. PubMed ID: 15361246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malaria in Tadjikistan: from control to elimination].
    Karimov SS; Sherkhonov TA; Saĭburkhonov DS
    Med Parazitol (Mosk); 2009; (1):23-6. PubMed ID: 19348311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vectors of malaria: biology, diversity, prevention, and individual protection].
    Pages F; Orlandi-Pradines E; Corbel V
    Med Mal Infect; 2007 Mar; 37(3):153-61. PubMed ID: 17306484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [European region program--"Roll Back Malaria": its results and prospects for its control].
    Ezhov MN; Zvantsov AB; Sergiev VP
    Med Parazitol (Mosk); 2004; (3):12-6. PubMed ID: 15484972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria vaccine trial endpoints - bridging the gaps between trial design, public health and the next generation of vaccines.
    O'Meara WP; Lang T
    Parasite Immunol; 2009 Sep; 31(9):574-81. PubMed ID: 19691560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas.
    Greenwood B
    Am J Trop Med Hyg; 2004 Jan; 70(1):1-7. PubMed ID: 14971690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.